Not applicableLooking for participantsNCT07206823
What this trial is testing
Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
Who this might be right for
Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 30